Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Baclofen formulations and methods of minimizing patient exposure to metabolite variations

Baclofen formulations and methods of minimizing patient exposure to metabolite variations

US Patent 11491125 · Granted Nov 8, 2022

Estimated economic value: $4,371,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Baclofen formulations and methods of minimizing patient exposure to metabolite v2025
Baclofen formulations and methods of minimizing patient exposure to metabolite v2025
Baclofen formulations and methods of minimizing patient exposure to metabolite v2025
Baclofen formulations and methods of minimizing patient exposure to metabolite v2025
Compositions and methods of administering baclofen2024
Compositions and methods of administering baclofen2024
Compositions and methods of administering baclofen2024
Compositions and methods of administering baclofen2024
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives2024
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives2024
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives2024
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives2024